https://orcid.org/0000-0002-8631-9308
References
- Drug Overdose Deaths. Drug Overdose. CDC Injury Center; 8 30, 2019 Available from: https://www.cdc.gov/drugoverdose/data/statedeaths.html. Accessed 1220, 2019.
- CDC. Guideline for prescribing opioids for chronic pain — United States, 2016. MMWR Recomm Rep. 2016;65. doi:10.15585/mmwr.rr6501e1er
- Fulton-Kehoe D, Garg RK, Turner JA, et al. Opioid poisonings and opioid adverse effects in workers in Washington State. Am J Ind Med. 2013;56(12):1452–1462. doi:10.1002/ajim.2226624122929
- Kaye AD, Garcia AJ, Hall OM, et al. Update on the pharmacogenomics of pain management. Pharmgenomics Pers Med. 2019;12:125–143. doi:10.2147/PGPM.S17915231308726
- Gene-specific Information Tables for CYP2D6. PharmGKB. Available from: https://www.pharmgkb.org/page/cyp2d6RefMaterials. Accessed 617, 2020.
- St Sauver JL, Olson JE, Roger VL, et al. CYP2D6 phenotypes are associated with adverse outcomes related to opioid medications. Pharmgenomics Pers Med. 2017;10:217–227. doi:10.2147/PGPM.S13634128769582
- Crews KR, Gaedigk A, Dunnenberger HM, et al. Clinical pharmacogenetics implementation consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update; 4 2014 Available from: https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/. Accessed 617, 2020.
- Takahashi PY, Ryu E, Pathak J, et al. Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6. Pharmgenomics Pers Med. 2017;10:39–47. doi:10.2147/PGPM.S11421128243137
- Melis R, Mohamed J, Ha Y, Lyon E, McMillin G. Postmortem CYP2D6 genotyping and copy number determinations using DNA extracted from archived FTA bloodstains. J Anal Toxicol. 2019;43(5):411–414. doi:10.1093/jat/bkz00830855675
- Caudle KE, Sangkuhl K, Whirl-Carrillo M, et al. Standardizing CYP2D6 genotype to phenotype translation: consensus recommendations from the clinical pharmacogenetics implementation consortium and dutch pharmacogenetics working group. Clin Transl Sci. 2020;13(1):116–124. doi:10.1111/cts.1269231647186
- Chanfreau-Coffinier C, Hull LE, Lynch JA, et al. Projected prevalence of actionable pharmacogenetic variants and level a drugs prescribed among US veterans health administration pharmacy users. JAMA Netw Open. 2019;2(6):e195345. doi:10.1001/jamanetworkopen.2019.534531173123
- Kennedy M. Interpreting postmortem drug analysis and redistribution in determining cause of death: a review. Pathol Lab Med Int. 2015;7:55–62. doi:10.2147/PLMI.S65245